TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CADILA PHARMS LTD

CardiovascularMetabolicOncology
Generics

CADILA PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Metabolic, Oncology. Key products include FLUOXETINE HYDROCHLORIDE.

2013
Since
29
Drugs
-
Trials
505
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
PREGABALIN 2026-02-24
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
PREGABALIN 2026-02-23
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
CELECOXIB 2026-02-12
Labeling
OLANZAPINE 2026-02-09
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 50%
4 drugs
Metabolic 25%
2 drugs
Oncology 13%
1 drugs
Dermatology 13%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Bayer big-pharma
Oncology, Cardiovascular, Dermatology, Metabolic
Merck big-pharma
Oncology, Cardiovascular, Metabolic
Baxter specialty
Cardiovascular, Oncology, Dermatology
Johnson & Johnson big-pharma
Oncology, Cardiovascular, Metabolic
Eli Lilly big-pharma
Metabolic, Oncology, Dermatology